Piramal Initiates Phase II Trial of Diabetes Drug

by Kathy Jones on  September 20, 2010 at 8:30 PM Clinical Trials News
RSS Email Print This Page Comment bookmark
Font : A-A+

One of India's leading pharmaceutical companies, Piramal Life Sciences has announced that it has started the phase-II study into its upcoming diabetic drug.
 Piramal Initiates Phase II Trial of Diabetes Drug
Piramal Initiates Phase II Trial of Diabetes Drug

The company's Managing Director Somesh Sharma revealed that the phase-II study of 'P1736-05' has been started and the company was confident of a successful completion of the study.

The P1736-05 is an insulin sensitizing compound which will be a part of the company's new drug for the treatment of type-2 diabetes in India and Europe.

"The commencement of phase-II trial of P1736-05 in India and Europe speaks of our efforts to build a diversified and strong pipeline of products to address unmet medical needs. P1736-05 is likely to provide a safe and effective therapeutic option to type-2 diabetic patients", Sharma added.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Diabetic Retinopathy Drug Toxicity Diabetes Diabetic Diet Diabetes - Essentials Diabetes - Self-Monitoring of Blood Glucose (SMBG) Insulin Delivery Devices Diabetes and Exercise Signature Drug Toxicity Stress Relief Through Alternative Medicine 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

Advertisement

News Category

News Archive